Drug Trial Radar · NCT07378865
Evaluation of the Excretion of Suzetrigine Into Breast Milk in Healthy Lactating Female Participants
Last checked: Nov 20, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
13
Actual
Start
Feb 13, 2026
Primary completion
Aug 17, 2026
Study completion Aug 17, 2026
Sponsor
- Lead sponsor
- Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
- Sponsor type
- Industry
- First posted
- Jan 30, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate the pharmacokinetics (PK) of suzetrigine (SUZ) and its active metabolite in breast milk of lactating female participants. In addition, the purpose is also to evaluate the relative infant dose (RID), safety and tolerability of SUZ and its active metabolite in lactating female participants.
Conditions
- Pain
Interventions
SuzetrigineDrug
Tablets for Oral Administration.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Total Amount of SUZ in Breast Milk of Lactating Female ParticipantsTime frame: From Day 1 up to Day 10
- Total Amount of SUZ Metabolite in Breast Milk of Lactating Female ParticipantsTime frame: From Day 1 up to Day 10
Locations
1 site in 1 country. Site status is shown where the registry gives one.
ICON - Utah - Salt Lake City Office
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.